135 related articles for article (PubMed ID: 6717166)
1. Thymine arabinoside (Ara-T) topical and iontophoretic application for herpes simplex virus type 1 and type 2 skin infections in hairless mice.
Hill JM; Wiggins CA; Kwon BS; Gentry GA; Gangarosa LP
Methods Find Exp Clin Pharmacol; 1984 Jan; 6(1):17-20. PubMed ID: 6717166
[TBL] [Abstract][Full Text] [Related]
2. Iontophoretic application of adenine arabinoside monophosphate to herpes simplex virus type 1-infected hairless mouse skin.
Park NH; Gangarosa LP; Kwon BS; Hill JM
Antimicrob Agents Chemother; 1978 Oct; 14(4):605-8. PubMed ID: 82423
[TBL] [Abstract][Full Text] [Related]
3. Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits.
Kwon BS; Gangarosa LP; Park NH; Hull DS; Fineberg E; Wiggins C; Hill JM
Invest Ophthalmol Vis Sci; 1979 Sep; 18(9):984-8. PubMed ID: 90030
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity and response to topical antiviral therapy in a murine model of acyclovir-sensitive and acyclovir-resistant herpes simplex viruses isolated from the same patient.
Lebel A; Boivin G
J Clin Virol; 2006 Sep; 37(1):34-7. PubMed ID: 16781887
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Herpes simplex virus infections with topical antiviral agents.
Hamuy R; Berman B
Eur J Dermatol; 1998; 8(5):310-9. PubMed ID: 9683881
[TBL] [Abstract][Full Text] [Related]
6. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
Park NH; Pavan-Langston D; McLean SL; Lass JH
Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
[TBL] [Abstract][Full Text] [Related]
7. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
[TBL] [Abstract][Full Text] [Related]
8. N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.
Hernandez AI; Familiar O; Negri A; Rodríguez-Barrios F; Gago F; Karlsson A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
J Med Chem; 2006 Dec; 49(26):7766-73. PubMed ID: 17181158
[TBL] [Abstract][Full Text] [Related]
9. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate.
Machida H; Sakata S; Morozumi M; Kiyanagi T; Kuninaka A; Yoshino H
Antiviral Res; 1982 Sep; 2(4):217-26. PubMed ID: 6293376
[TBL] [Abstract][Full Text] [Related]
11. Combined chemotherapy of cutaneous herpes simplex infection of the guinea pig.
Burkhardt U; Wigand R
J Med Virol; 1983; 12(2):137-47. PubMed ID: 6194252
[TBL] [Abstract][Full Text] [Related]
12. Influence of the treatment protocol upon the in vivo efficacy of cidofovir (HPMPC) and of acyclovir (ACV) formulations in topical treatment of cutaneous HSV-1 infection in hairless mice.
Afouna MI; Mehta SC; Ghanem AH; Higuchi WI; Kern ER; DeClercq E; El-Shattawy HH
J Pharm Sci; 1999 May; 88(5):530-4. PubMed ID: 10229644
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of orally administered Lobelia chinensis extracts on herpes simplex virus type 1 infection in BALB/c mice.
Kuo YC; Lee YC; Leu YL; Tsai WJ; Chang SC
Antiviral Res; 2008 Nov; 80(2):206-12. PubMed ID: 18621082
[TBL] [Abstract][Full Text] [Related]
14. Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.
Lee PH; Su MH; Kern ER; Higuchi WI
Pharm Res; 1992 Aug; 9(8):979-89. PubMed ID: 1329068
[TBL] [Abstract][Full Text] [Related]
15. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
Shannon WM; Westbrook L; Higuchi WI; Sugibayashi K; Baker DC; Kumar SD; Fox JL; Flynn GL; Ho NF; Vaidyanathan R
J Pharm Sci; 1985 Nov; 74(11):1157-61. PubMed ID: 4087174
[TBL] [Abstract][Full Text] [Related]
16. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
[TBL] [Abstract][Full Text] [Related]
17. Timolol induces HSV-1 ocular shedding in the latently infected rabbit.
Hill JM; Shimomura Y; Dudley JB; Berman E; Haruta Y; Kwon BS; Maguire LJ
Invest Ophthalmol Vis Sci; 1987 Mar; 28(3):585-90. PubMed ID: 3030959
[TBL] [Abstract][Full Text] [Related]
18. Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice.
Docherty JJ; Smith JS; Fu MM; Stoner T; Booth T
Antiviral Res; 2004 Jan; 61(1):19-26. PubMed ID: 14670590
[TBL] [Abstract][Full Text] [Related]
19. Increased penetration of nonelectrolytes into mouse skin during iontophoretic water transport (iontohydrokinesis).
Gangarosa LP; Park NH; Wiggins CA; Hill JM
J Pharmacol Exp Ther; 1980 Mar; 212(3):377-81. PubMed ID: 7359341
[TBL] [Abstract][Full Text] [Related]
20. Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound in vitro and in vivo.
Kurokawa M; Hozumi T; Tsurita M; Kadota S; Namba T; Shiraki K
J Pharmacol Exp Ther; 2001 Apr; 297(1):372-9. PubMed ID: 11259565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
